Insider Selling: Phreesia, Inc. (NYSE:PHR) CFO Sells $50,169.42 in Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 1,827 shares of the company’s stock in a transaction on Wednesday, March 26th. The stock was sold at an average price of $27.46, for a total value of $50,169.42. Following the sale, the chief financial officer now owns 103,591 shares of the company’s stock, valued at $2,844,608.86. This trade represents a 1.73 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, February 18th, Balaji Gandhi sold 5,771 shares of Phreesia stock. The stock was sold at an average price of $30.04, for a total transaction of $173,360.84.
• On Thursday, February 13th, Balaji Gandhi sold 28,759 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total transaction of $862,770.00.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total transaction of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Stock Performance

Phreesia stock opened at $26.00 on Monday. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.53 billion, a PE ratio of -17.69 and a beta of 1.03. The firm’s 50 day simple moving average is $27.38 and its 200 day simple moving average is $24.19.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on PHR shares. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their target price for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Robert W. Baird reduced their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Needham & Company LLC restated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research note on Thursday, March 13th. Piper Sandler reiterated an “overweight” rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, Canaccord Genuity Group boosted their price objective on Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia has a consensus rating of “Buy” and an average price target of $31.33.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in PHR. Deerfield Management Company L.P. Series C grew its position in Phreesia by 133.6% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company’s stock worth $31,999,000 after buying an additional 727,384 shares in the last quarter. Greenhouse Funds LLLP increased its holdings in shares of Phreesia by 27.9% in the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock worth $72,307,000 after buying an additional 626,579 shares during the last quarter. Park West Asset Management LLC purchased a new stake in shares of Phreesia during the 4th quarter valued at $10,657,000. Millennium Management LLC lifted its holdings in shares of Phreesia by 83.2% during the 4th quarter. Millennium Management LLC now owns 653,634 shares of the company’s stock worth $16,445,000 after acquiring an additional 296,863 shares during the last quarter. Finally, ExodusPoint Capital Management LP grew its position in Phreesia by 448.6% in the fourth quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company’s stock worth $4,402,000 after acquiring an additional 143,077 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.